KBI Biopharma is a UK-based private equity firm investing in British SMEs, especially owner-managed businesses in manufacturing, precision engineering, bespoke fabrication, medical and scientific instrumentation, and new product development. It backs buyout and acquisition-oriented transactions, supports transitions toward employee-managed models, and provides capital, mentorship, and operational support. The firm has acted as a lead investor and is most relevant for UK companies in manufacturing, industrial technology, medical devices, and life sciences.